Both insulin and beta amyloid are degraded by the insulin-degrading enzyme (IDE); thus, hyperinsulinemia present in DM patients may competitively affect the increase in beta amyloid accumulation [44,105]. The gene discussed is INS; the disease is Hyperinsulinemia.